Ads
related to: eau guidelines prostate cancer 2019 2020- Patient Resources
Download informative brochures for
patients and caregivers.
- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- About Us
Understand how a PSMA PET scan may
help with your treatment plan.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Patient Resources
Search results
Results from the WOW.Com Content Network
An additional example of EAU collaboration with another organisation for the benefit of urology is the World Health Organization (WHO) Consensus Conference on bladder cancer, which was held in April 2008. The European Association of Urology Nurses (EAUN) aims to contribute to the development of higher standards of urology nursing in Europe.
Surgical removal of the prostate, or prostatectomy, is a common treatment either for early-stage prostate cancer or for cancer that has failed to respond to radiation therapy. The most common type is radical retropubic prostatectomy , when the surgeon removes the prostate through an abdominal incision.
Radical retropubic prostatectomy is typically performed in men who have early stage prostate cancer. Early stage prostate cancer is confined to the prostate gland and has not yet spread beyond the prostate or to other parts of the body. Attempts are made prior to surgery, through medical tests such as bone scans, computed tomography (CT), and ...
The American Urological Association (AUA) guidelines for the treatment of BPH from 2018 list minimally invasive therapies including TUMT - but not TUNA - as acceptable alternatives for certain patients with BPH. [11] However, the European Association of Urology (EAU) has - as of 2019 - removed both TUMT and TUNA from its guidelines. [15]
Prostate cancer is a major topic of ongoing research. From 2016–2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [123] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost. [124]
In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...
Ads
related to: eau guidelines prostate cancer 2019 2020